Related Experiment Videos
Clinical aspects of cardiomyopathy in dialysis patients
1Division of Nephrology, Health Sciences Centre, St. John's, Nfld., Canada.
Insights
Cardiac disease is common and serious in dialysis patients, predicting poor outcomes. Further research is needed to identify effective interventions for cardiomyopathy in chronic kidney disease.
Area of Science:
- Nephrology
- Cardiology
Background:
- Dialysis patients face a high burden of cardiac disease.
- Conditions like congestive heart failure, ischemic heart disease, and left ventricular hypertrophy are prevalent and linked to poor prognosis.
- Anemia, hypoalbuminemia, hypotension, and low serum creatinine are mortality predictors during dialysis.
Purpose of the Study:
- To review the cardiac disease burden in dialysis patients.
- To identify risk factors for systolic dysfunction and left ventricular hypertrophy.
- To explore potential interventions for cardiomyopathy in chronic uremia.
Main Methods:
- Literature review and synthesis of existing data on cardiac disease in dialysis patients.
- Analysis of risk factors associated with specific cardiac conditions.
- Identification of potential therapeutic interventions.
Main Results:
- Frequent occurrence of congestive heart failure, ischemic heart disease, left ventricular hypertrophy, and systolic dysfunction.
- Identified risk factors for systolic dysfunction (older age, ischemic heart disease, hyperparathyroidism, smoking) and left ventricular hypertrophy (older age, hypertension, anemia, diabetes mellitus).
- Potential interventions include hematocrit normalization with erythropoietin, improved uremia management, and ACE inhibitors.
Conclusions:
- Cardiac disease significantly impacts dialysis patients' prognosis.
- Specific risk factors contribute to systolic dysfunction and left ventricular hypertrophy.
- Urgent trials are needed to establish optimal interventions for cardiomyopathy in chronic uremia.
Abstract:
The burden of cardiac disease in dialysis patients is high. Congestive heart failure, ischemic heart disease, left ventricular hypertrophy, and systolic dysfunction occur frequently and are associated with an adverse prognosis. In addition, during dialysis therapy anemia, hypoalbuminemia, low blood pressure, and lower serum creatinine levels are adverse predictors of mortality. Risk factors for systolic dysfunction include older age, ischemic heart disease, hyperparathyroidism, and smoking. Risk factors for left ventricular hypertrophy include older age, hypertension, anemia, and diabetes mellitus. Interventions with potential for improving cardiomyopathy include normalization of hematocrit with erythropoietin, improved uremia therapy, and angiotensin-converting enzyme inhibitors. Trials to determine the most appropriate interventions to reduce the impact of cardiac disease in chronic uremia are urgently required.